These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 30698293)
21. Design and development of ((4-methoxyphenyl)carbamoyl) (5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl)amide analogues as Mycobacterium tuberculosis ketol-acid reductoisomerase inhibitors. Krishna VS; Zheng S; Rekha EM; Nallangi R; Sai Prasad DV; George SE; Guddat LW; Sriram D Eur J Med Chem; 2020 May; 193():112178. PubMed ID: 32171154 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents. Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715 [TBL] [Abstract][Full Text] [Related]
23. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis. Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and structure activity relationship of imidazo[1,2-a]pyridine-8-carboxamides as a novel antimycobacterial lead series. Ramachandran S; Panda M; Mukherjee K; Choudhury NR; Tantry SJ; Kedari CK; Ramachandran V; Sharma S; Ramya VK; Guptha S; Sambandamurthy VK Bioorg Med Chem Lett; 2013 Sep; 23(17):4996-5001. PubMed ID: 23867166 [TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents. Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048 [TBL] [Abstract][Full Text] [Related]
26. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds. Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel [1,2]-diamines with antituberculosis activity. Meng Q; Luo H; Chen Y; Wang T; Yao Q Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents. Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836 [TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents. Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612 [TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of Zhang NN; Liu ZY; Liang J; Tang YX; Qian L; Gao YM; Zhang TY; Yan M Medchemcomm; 2018 Aug; 9(8):1293-1304. PubMed ID: 30151083 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. Kumar S; Dwivedi AP; Kashyap VK; Saxena AK; Dwivedi AK; Srivastava R; Sahu DP Bioorg Med Chem Lett; 2013 Apr; 23(8):2404-7. PubMed ID: 23474387 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues. Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688 [TBL] [Abstract][Full Text] [Related]
33. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. Sriram D; Yogeeswari P; Devakaram RV Bioorg Med Chem; 2006 May; 14(9):3113-8. PubMed ID: 16412646 [TBL] [Abstract][Full Text] [Related]
35. Development and Evaluation of Bis-benzothiazoles as a New Class of Benzothiazoles Targeting DprE1 as Antitubercular Agents. Samoon R; Sau S; Roy A; Parida KK; Sharma K; Yakkala PA; Dewangan RP; Abdin MZ; Kalia NP; Shafi S ACS Infect Dis; 2024 Sep; 10(9):3320-3331. PubMed ID: 39150887 [TBL] [Abstract][Full Text] [Related]
36. Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives. Avalos-Alanís FG; Hernández-Fernández E; Carranza-Rosales P; López-Cortina S; Hernández-Fernández J; Ordóñez M; Guzmán-Delgado NE; Morales-Vargas A; Velázquez-Moreno VM; Santiago-Mauricio MG Bioorg Med Chem Lett; 2017 Feb; 27(4):821-825. PubMed ID: 28117200 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and antituberculosis activity of new fatty acid amides. D'Oca Cda R; Coelho T; Marinho TG; Hack CR; Duarte Rda C; da Silva PA; D'Oca MG Bioorg Med Chem Lett; 2010 Sep; 20(17):5255-7. PubMed ID: 20667727 [TBL] [Abstract][Full Text] [Related]
38. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis. Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST mBio; 2018 Oct; 9(5):. PubMed ID: 30301850 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and In vitro antituberculosis activity of 2(5H)-Furanone derivatives. Ngwane AH; Panayides JL; Chouteau F; Macingwana L; Viljoen A; Baker B; Madikane E; de Kock C; Wiesner L; Chibale K; Parkinson CJ; Mmutlane EM; van Helden P; Wiid I IUBMB Life; 2016 Aug; 68(8):612-20. PubMed ID: 27346745 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives. Li YB; Xie YY; Du NN; Lu Y; Xu HZ; Wang B; Yu Y; Liu YX; Song DQ; Chen RX Bioorg Med Chem Lett; 2011 Nov; 21(22):6804-7. PubMed ID: 21982497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]